Fort Myers, Florida - March 03, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational ...
The device, which is cleared by the FDA for withdrawal mitigation from opioid use disorder, works by abating severe symptoms such as stomach aches, back aches, sweats, and the inability to keep food ...
TAMPA, FL - March 05, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has released a new educational resource ...
NEWARK, DE - March 03, 2026 - PRESSADVANTAGE - AqueLyst has issued an operational update to outline its molecular ...
State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, ...
BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid withdrawal symptoms Results from this ...
Zurich, Zurich - March 03, 2026 - PRESSADVANTAGE - Zahnarztbleaching, Switzerland's comprehensive guide to professional ...
Fort Myers, Florida - March 04, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational ...
New York, New York - March 03, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has announced continued development and ...
Flynn Greathouse Launched a New Personal Injury Claims Quiz To Give Accident Victims Insights Into Potential Claims, ...
Community golf tournament at Topgolf aims to raise the final $10,000 for backup generators protecting Sunnyhill ...
Trillion Parameter run achieved with DeepSeek R1 671B model on 36 Nvidia H100 GPUs We are pleased to offer a Trillion ...